June 11th 2025
Late-breaking data reveal durable improvements in joint, skin, and quality of life outcomes with deucravacitinib.
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape
Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies
Managed Care Approaches to Individualize Treatment of Hereditary Angioedema
From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
Leveraging Biologics and Immunotherapies in the Management of Food Allergies
Reflecting on the Real-World Use of Biologic Therapy in Asthma Management
Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden
Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition
Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches
The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care